X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (577) 577
Book Review (76) 76
Conference Proceeding (72) 72
Publication (47) 47
Book / eBook (3) 3
Book Chapter (1) 1
Patent (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
oncology (307) 307
index medicus (279) 279
humans (264) 264
female (161) 161
male (148) 148
middle aged (140) 140
aged (137) 137
adult (109) 109
chemotherapy (105) 105
cancer (92) 92
antineoplastic combined chemotherapy protocols - therapeutic use (74) 74
treatment outcome (69) 69
prognosis (63) 63
metastasis (61) 61
antineoplastic agents - therapeutic use (53) 53
survival (53) 53
therapy (49) 49
hematology, oncology and palliative medicine (46) 46
care and treatment (44) 44
neoplasm staging (44) 44
aged, 80 and over (42) 42
colorectal cancer (41) 41
disease-free survival (41) 41
tumors (39) 39
colorectal neoplasms - drug therapy (37) 37
analysis (36) 36
settore med/06 - oncologia medica (35) 35
lung neoplasms - drug therapy (33) 33
trial (31) 31
hematology (30) 30
survival analysis (28) 28
colorectal neoplasms - pathology (27) 27
immunotherapy (27) 27
mutation (27) 27
neoplasm metastasis (27) 27
retrospective studies (27) 27
surgery (27) 27
antineoplastic combined chemotherapy protocols - adverse effects (26) 26
carcinoma (26) 26
lung neoplasms - pathology (26) 26
breast cancer (25) 25
carcinoma, non-small-cell lung - drug therapy (25) 25
research (25) 25
respiratory system (25) 25
clinical trials (24) 24
risk factors (24) 24
metastases (23) 23
targeted therapy (23) 23
bevacizumab (22) 22
patients (22) 22
survival rate (22) 22
drug therapy (21) 21
immunohistochemistry (21) 21
kidney neoplasms - drug therapy (21) 21
molecular targeted therapy (21) 21
antineoplastic agents - adverse effects (20) 20
carcinoma, renal cell - drug therapy (20) 20
double-blind (20) 20
medicine & public health (20) 20
phase-ii (20) 20
toxicity (20) 20
carcinoma, non-small-cell lung - pathology (19) 19
efficacy (19) 19
health aspects (19) 19
neuroendocrine tumors (19) 19
phase-iii trial (19) 19
radiotherapy (19) 19
angiogenesis (18) 18
cancer therapies (18) 18
colorectal neoplasms - genetics (18) 18
drug administration schedule (18) 18
follow-up studies (18) 18
prospective studies (18) 18
antineoplastic agents - administration & dosage (17) 17
combination (17) 17
combined modality therapy (17) 17
fluorouracil (17) 17
gastric cancer (17) 17
medical prognosis (17) 17
open-label (17) 17
pharmacology & pharmacy (17) 17
renal cell carcinoma (17) 17
1st-line treatment (16) 16
antineoplastic combined chemotherapy protocols - administration & dosage (16) 16
cetuximab (16) 16
disease progression (16) 16
expression (16) 16
fluorouracil - administration & dosage (16) 16
kaplan-meier estimate (16) 16
phase-iii (16) 16
sunitinib (16) 16
abridged index medicus (15) 15
adenocarcinoma (15) 15
biomarkers (15) 15
cancer patients (15) 15
cisplatin (15) 15
gemcitabine (15) 15
management (15) 15
neoplasms - drug therapy (15) 15
protein kinase inhibitors - therapeutic use (15) 15
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 05/2019, Volume 37, Issue 15_suppl, pp. e23147 - e23147
Journal Article
Critical Reviews in Oncology and Hematology, ISSN 1040-8428, 2002, Volume 41, Issue 1, pp. 89 - 106
Journal Article
Pharmacogenomics, ISSN 1462-2416, 2018, Volume 19, Issue 13, pp. 1047 - 1068
Gastric cancer is a highly heterogeneous disease, displaying a complex genomic landscape and an unfavorable outcome with standard therapies. Based on... 
gastric cancer | targeted therapy | resistance | OPEN-LABEL | PATIENT-DERIVED XENOGRAFT | TRASTUZUMAB RESISTANCE | GROWTH-FACTOR RECEPTOR | PHASE-II TRIAL | DOUBLE-BLIND | TYROSINE KINASE INHIBITOR | PHARMACOLOGY & PHARMACY | GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA | 1ST-LINE THERAPY | PATIENTS PTS
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 03/2019, Volume 37, Issue 7_suppl, pp. 578 - 578
Journal Article
The Oncologist, ISSN 1083-7159, 3/2015, Volume 20, Issue 3, pp. e5 - e5
The authors are currently conducting molecular and genetic research to identify new targets for therapeutic interventions and predictive biomarkers in... 
6 | Letters to the Editor
Journal Article
MELANOMA RESEARCH, ISSN 0960-8931, 06/2019, Volume 29, Issue 3, pp. 289 - 294
Pembrolizumab is an anti-programmed cell death-1 monoclonal antibody, currently representing the first-line treatment for advanced melanoma. Apart from... 
MEDICINE, RESEARCH & EXPERIMENTAL | anti-programmed cell death 1 | pembrolizumab | ONCOLOGY | immunotherapy | TUMOR RESPONSE | melanoma | IPILIMUMAB | CHEMOTHERAPY | DERMATOLOGY
Journal Article
TUMORI J, ISSN 0300-8916, 12/2018, Volume 104, Issue 6, pp. NP10 - NP13
Introduction: Signet-ring cell (SRC) carcinoma is a common subtype of gastric adenocarcinoma associated with poor prognosis. Metastatic involvement of the... 
Immunohistochemistry | Parotid gland | ONCOLOGY | Cytokeratins | Bilateral parotid metastases | Signet-ring cell | Gastric cancer | STOMACH
Journal Article
Oncotarget, ISSN 1949-2553, 2018, Volume 9, Issue 23, pp. 16437 - 16450
A number of pharmacogenetic studies have been carried out in non-small-cell lung cancer (NSCLC) to identify and characterize genes involved in chemotherapy... 
Nucleotidase | Response | Pharmacogenetics | Gemcitabine | Lung cancer
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 7, pp. 883 - 895
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.